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Background. Prostasin has been shown to be involved in the
regulation of sodium handling in the kidney. TGF-b1 has been
demonstrated to suppress aENaC expression and sodium up-
take. Therefore, we hypothesized that TGF-b1 may regulate
prostasin expression to modulate sodium reabsorption in the
kidney.
Methods. To determine if TGF-b1 has an effect on prostasin
expression, we isolated 2.9 kb of the rat prostasin promoter,
and measured its transcriptional activity with a luciferase assay
in mouse cortical collecting duct cell line (M-1). The effect of
TGF-b1 on the mRNA and protein abundance of prostasin, and
amiloride-sensitive 22Na uptake was determined.
Results. Treatment of M-1 cells with 20 ng/mL of TGF-b1 for
24 hours significantly decreased the promoter activity by 50 ±
1%, and the inhibitory effect was dose dependent over the range
of 0.1 to 20 ng/mL. We identified a 50 bp region (−410 to −360)
containing c-Rel–like sequence in prostasin promoter that is re-
sponsible for the TGF-b1–mediated inhibition, and found that
TGF-b1 increases IjBa expression in M-1 cells. TGF-b1 re-
duced endogenous prostasin mRNA and protein expression in
M-1 cells by 50 ± 12% and 44 ± 12%, respectively, and the
amiloride-sensitive 22Na uptake by 35.9 ± 4.8%.
Conclusion. Our findings indicate the possibility that TGF-b1
transcriptionally inhibits prostasin expression by the induction
of IjBa and the subsequent inhibition of NF-jB/Rel activity in
M-1 cells, and also suggest the possibility that TGF-b1 might
inhibit sodium reabsorption through a reduction in prostasin
expression and subsequent inhibition of ENaC activity.
Sodium balance, extracellular fluid volume and, ulti-
mately, blood pressure, are maintained by precise regula-
tion of the activity of epithelial sodium channels (ENaC)
[1–3]. Multiple mechanisms, such as hormones, intra-
cellular factors, and other regulatory factors contribute
to the regulation of ENaC activity. Prostasin/CAP-1
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is a glycosylphosphatidylinositol (GPI)-anchored ser-
ine protease expressed in kidney, prostate, colon, and
lung, as well as in body fluids, including seminal fluid
and urine [4, 5]. Prostasin/CAP-1 stimulates the activ-
ity of ENaC when they are coexpressed in Xenopus
oocytes [6–8]. In addition, we showed that aldosterone
increases the expression of prostasin in both in vitro and
in vivo conditions [9]. These results indicate that prostasin
is an important physiologic regulator of sodium reab-
sorption in the kidney through EnaC, and suggest the
possibility that prostasin is involved in the development
of salt-sensitive hypertension. Recently, this possibility
was supported by the findings by Wang et al [10], who
demonstrated that a single injection of adenovirus carry-
ing the prostasin gene caused a prolonged (3 to 4 weeks)
increase in blood pressure and plasma aldosterone con-
centration in rats. These findings suggest that prostasin
may play an important role in the regulation of blood
pressure and electrolyte balance via regulation of the
renin-angiotensin-aldosterone system.
Transforming growth factor-b (TGF-b) is a multifunc-
tional cytokine that regulates a wide variety of cellular
activities in many tissues and organs. It is synthesized
by virtually all cell types, with only a few exceptions
[11, 12]. TGF-b has been shown to antagonize the ac-
tion of aldosterone on sodium transport by the rat in-
ner medullary collecting ducts in primary culture [13–16].
Although the mechanism of this antagonism is not fully
understood, TGF-b has been suggested to induce post-
transcriptional modification of ENaC. Previously, Ying
et al demonstrated that a high salt diet induces an increase
in synthesis and excretion of TGF-b in the kidney in rats
[17]. Additionally, a significant correlation was observed
between urinary TGF-b excretion and urinary sodium
excretion in patients with type 2 diabetes and diabetic
nephropathy [18]. Therefore, we hypothesized that TGF-
b1 may regulate the expression of prostasin to modulate
sodium reabsorption in the kidney.
The present study was conducted to investigate the ef-
fect of TGF-b1 on the expression of prostasin and 22Na
uptake in M-1 mouse cortical collecting duct (CCD) cells.
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We isolated the rat prostasin promoter and studied the
effect of TGF-b1 on its transcriptional activity, as well as
on the expression of prostasin mRNA and protein in M-1
cells. We found that TGF-b1 inhibits the transcription,
mRNA expression, and protein expression of prostasin.
We identified a 50 bp region containing c-Rel like mo-
tif that is responsible for this inhibition, and demon-
strated that TGF-b1–mediated IkBa induction might be
involved in this inhibition. We also found that TGF-
b1 suppressed amiloride-sensitive 22Na uptake in M-1
cells. These results strongly suggest the possibility that
prostasin may play a role in TGF-b1–induced modula-
tion of sodium handling in the kidney.
METHODS
Cloning of the rat prostasin gene promoter
The 5′-flanking region of prostasin was isolated from
a rat genomic library using the GenomWalker kit
(Clontech, Palo Alto, CA, USA) following the manufac-
turer’s instructions. For the first genomic walk, the pri-
mary round of polymerase chain reaction (PCR) ampli-
fication used antisense gene specific primer 1 (5′-GAAG
GCTGGTTTGGAAGTCAGGATCTAG-3′) and an
adaptor primer 1 (5′-GTAATACGACTCACTATAGG
GC-3′). The second genomic walk used an antisense
gene specific primer 2 (5′-ACGGGACACGCCTTTGG
TCTCTGTAGT-3′) and adaptor primer 2 (5′-ACTAT
AGGGCACGCGTGGT-3′), with the primary PCR
product as the template. The secondary PCR products
were subcloned into pGEM-T easy vector (Promega,
Madison, WI, USA), and sequenced using the dideoxy
chain termination method with fluorescent dye-labeled
terminators on an automated sequencer (ABI model
310; Applied Biosystems, Foster City, CA, USA).
Identification of the transcription initiation site
The transcription initiation site of the isolated rat
prostasin promoter was identified using the GeneRacer
kit (Invitrogen, Carlsbad, CA, USA) based on the RNA
ligation-mediated rapid amplification of 5′-cDNA end
(5′-RLM-RACE) method. In brief, rat kidney mRNA
was treated with calf intestine phosphatase, then with
tobacco acid pyrophosphatase. Next, the full-length
decapped mRNAs were annealed to the GeneRacer
RNA oligonucleotide (provided in the kit), and the
RNAs were reverse-transcribed by random primers.
The initial PCR was performed using GeneRacer 5′-
primer (provided in the kit) and a primer complemen-
tary to rat prostasin cDNA sequence (GSP1; 5′-TGG
TGGGCCCCCAGCTTTACCT-3′). Nested PCR was
then performed using the GeneRacer 5′-primer and
gene specific primer (GSP2; 5′-GATGCTGACCTGCC
AGGGCCATTGA-3′), using first PCR product as the
template. The nested PCR products were subcloned into
the pGEM-T easy vector and sequenced as described
above.
Cell culture
M-1 cells, an SV 40-transformed mouse CCD cell line,
were obtained from the American Type Culture Collec-
tion (Rockville, MD, USA). Cells were maintained as pre-
viously described [19], and experiments were performed
when cells were confluent. Both serum and dexametha-
sone were removed 24 hours before experiments. All
studies described in this paper were performed on cells
between the 5th and 20th passages.
Transfection and luciferase assay
The isolated rat prostasin promoter was subcloned into
the pGL3-basic vector carrying a firefly luciferase re-
porter gene (Promega). Exponentially growing cells were
trypsinized and seeded at a density of 3.5 × 105 cells/well
in 6-well plates 24 hours before transfection. Ten mi-
crograms of the prostasin promoter-luciferase construct
and 3 ng of phRL-CMV vector carrying a luciferase Re-
nilla luciferase gene (Promega) were cotransfected into
M-1 cells using the calcium phosphate-method. Twenty-
four hours after transfection, cells were washed twice
with phosphate-buffered saline (PBS), and the media
were then replaced with serum free media. At this stage,
the various solutions with different TGF-b1 concentra-
tions were added. Cells were harvested 6 to 48 hours
after various treatments, and promoter activities were
measured using the luciferase assay. The luciferase assay
was performed with the Dual-Luciferase Reporter Assay
System (Promega), as previously described [20], using a
Luminometer TD-20/20 (Turner Designs, Sunnyvale, CA,
USA). The ratio of firefly luciferase activity to Renilla
luciferase activity was used to determine prostasin pro-
moter activity and expressed as relative luciferase activ-
ity. The analysis of each prostasin promoter construct was
performed in triplicates in 4 independent experiments.
Northern blot analysis
Total RNAs from M-1 cells grown in 10-cm plastic
dishes under experimental conditions were isolated by
using an RNeasy kit (Qiagen, Hilden, Germany). Total
RNA (20 lg) of each sample was resolved on agarose-
formaldehyde gels, and transferred onto nylon mem-
branes. A full-length cDNA of mouse prostasin and rat
b-actin was individually labeled with [a-32P] dCTP and
probes were hybridized with the membranes, as described
previously [6]. The band densities were quantitated with
densitometry (densitograph 4.0; ATTO, Tokyo, Japan).
Antibody generation
To produce polyclonal antibody against rat and
mouse prostasin, a short peptide sequence, NH2-PQTQ
ESQPDGHLC-COOH, was synthesized, based on
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predicted amino acid sequence in rat and mouse. The
sequence was chosen for specificity, antigenicity, and
absence of likely post-translational modifications us-
ing computer analysis. The peptide is high-performance
liquid chromatography (HPLC)-purified, conjugated to
keyhole limpet hemocyanin, and used for immunization
of rabbits using standard immunization protocols. The re-
sulting antisera were affinity-purified against the immu-
nizing peptide. The specificity of the antibody was eval-
uated by comparing the blots with previously reported
antibody [9, 19].
Preparation of proteins and immunoblottings
After incubation under experimental conditions, cul-
ture medium (10 mL/10 cm dish) was collected, and cen-
trifuged at 1200g to pellet cell debris. Total protein in
the culture media was precipitated by trichloroacetic acid
(TCA) (final concentration: 15%). The samples were
centrifuged at 12,000g, and the pellets were washed 3
times with ice-cold 80% acetone. The precipitated pro-
teins were dried and solubilized at 100◦C for 5 min-
utes in 1 × TCA buffer [200 mmol/L unbuffered Tris,
1% sodium dodecyl sulfate (SDS), 10% glycerol, 1%
b-mercaptoethanol]. For preparation of membrane and
cytosolic fractions of M-1 cells, confluent M-1 cells
were washed twice with PBS, scraped into lysis buffer
(25 mmol/L Tris-HCl, pH 7.5, 4 lg/mL aprotinin, 4 lg/mL
leupeptin, 1 mmol/L PMSF, and 4 lg/mL pepstatin A),
and lysed in a glass Dounce homogenizer. The ho-
mogenate was centrifuged at 800g to remove nuclei, and
the supernatant was centrifuged at 12,000g to separate
the membrane and cytosolic fractions. The membrane
fraction was then dissolved in RIPA buffer (50 mmol/L
Tris-HCl, pH 7.5, 150 mmol/L NaCl, 0.1% SDS, 0.5% de-
oxycholate, 1% (V/V) Triton-X 100, 2 mmol/L EDTA,
4 lg/mL aprotinin, 4 lg/mL leupeptin, 1 mmol/L PMSF,
and 4 lg/mL pepstatin A). All of these procedures were
performed at 4◦C. Samples were size fractionated on 12%
SDS-polyacrylamide gels and transferred onto nitrocel-
lulose filters. After blocking with 5 g/dL nonfat dry milk,
the blots were probed with a polyclonal antibody against
prostasin or a polyclonal antibody against IjBa (Santa
Cruz Biotechnology, Inc., Santa Cruz, CA, USA) in Tris-
buffered saline with 0.05% Tween-20 for 1 hour, followed
by a secondary antibody (goat antirabbit IgG-conjugated
with horseradish peroxidase) for 1 hour at room tem-
perature. Bands were visualized using chemilumines-
cence substrate (ECL; Amersham Pharmacia Biotech,
Buckinghamshire, England) before exposure to x-ray
film. The band densities were quantitated by densitome-
try (Densitograph 4.0; ATTO).
22Na influx studies
The activities of ENaC in M-1 cells were deter-
mined by measurement of amiloride-sensitive 22Na up-
take, as previously described [9]. Briefly, after incuba-
tion under experimental conditions, cells on 6-well plates
were rinsed twice and preincubated for 15 minutes at
37◦C in an Na-free solution composed of (in mmol/L)
137 N-methylglucamine (NMDG), 5.4 KCl, 1.2 MgSO4,
2.8 CaCl2, and 15 HEPES (pH 7.4). At the end of
the preincubation, the Na-free solution was replaced by
the uptake solution composed of (in mmol/L) 14 NaCl,
35 KCl, 96 NMDG, and 20 HEPES (pH 7.4) containing
1 mmol/L ouabain and 1.5 lCi/mL of 22NaCl (specific
activity: 748 lCi/mg Na, Perkin Elmer, Wellesley, MA,
USA) in the presence or absence 1 mmol/L amiloride.
After a 5-minute incubation, uptake was stopped by
washing the cells 4 times with 1 mL/well of an ice-cold so-
lution containing (in mmol/L) 120 NMDG and 20 HEPES
(pH 7.4). The cells were then solubilized in 0.5% Triton
X-100. Tracer activities were measured in a gamma scin-
tillation counter. All assays were performed in triplicate.
ENaC activity was determined as the difference between
22Na uptake in the presence or absence of amiloride. The
results were expressed as cpm/well.
Statistical analysis
Statistical significance was evaluated using the two-
tailed, unpaired Student t test for comparisons be-
tween 2 means, or analysis of variance (ANOVA)
analysis followed by Newman-Keuls method for more
than 2 means. A value of P < 0.05 was regarded as
statistically significant.
RESULTS
Cloning of the rat prostasin gene promoter and mapping
of the transcription initiation site
We isolated the rat prostasin promoter from Sprague-
Dawley rat genomic DNA library. The promoter frag-
ment we isolated was 2903 bp in length. This fragment also
contained the 5′-end of the rat cDNA sequence (Fig. 1).
A number of potential regulatory elements were found in
this promoter region by comparison with established con-
sensus sequences. There are 2 AP-1 sites at nucleotides
from −2237 to −2229 and from −630 to −622, a c-Rel
site from −407 to −397, a CCAAT box from −191 to
−180, a C/EBP site from −170 to −158, and a GC box
from −63 to −50 (Fig. 1). No TATA box could be iden-
tified in the promoter region, as is also the case with the
human and mouse prostasin promoters [21, 22]. In order
to identify the transcription initiation site of the prostasin
promoter, 5′-RLM-RACE was performed. Two gene spe-
cific primers were used for the 5′-RLM-RACE, and their
location is shown in Figure 2B (nucleotides 385 to 409
and 509 to 534 of the prostasin cDNA). Sequence anal-
ysis of the 5′-RLM-RACE products revealed 2 different
transcription initiation sites in the rat prostasin promoter.
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Fig. 1. Nucleotide sequence of 5′ flanking region of rat prostasin gene.
A total of 2903 bp of 5′ flanking region of the rat prostasin gene was
isolated and sequenced. Nucleotides are numbered relative to the first
transcription initiation site (nucleotide +1; arrow). Sequence analysis
identified two AP-1 sites, a c-Rel site, a CCAAT box, a GC box, and
a C/EBP site in this promoter. The second transcription start site is
marked by an asterisk. “M” indicates the first amino acid (methionine)
of rat prostasin. The complete nucleotide sequence of the rat prostasin
gene promoter is available in the Genbank under the accession number
(AB073913).
These are located at 224 and 207 bp, upstream from ATG
codon (Fig. 2B).
Transcriptional activity of prostasin promoter in M-1 cells
We used M-1 cells to characterize the transcriptional
activity of the rat prostasin promoter because prostasin
Anchor  primerAnchor  primer
Initiation site Initiation site
A B
Fig. 2. Identification of the transcription initiation site by 5′ RLM-
RACE. (A) Agarose gel electrophoresis of nested PCR reaction prod-
ucts from 5′-RLM-RACE using rat mRNA. Molecular size markers
(base pairs) are indicated on the left. Arrow on the right identifies the
PCR products. (B) Sequence analysis of the 5′-RLM-RACE products
revealed 2 different transcription initiation sites in the rat prostasin
promoter. The arrows above the sequence indicate the transcription
initiation sites. Underlined sequences indicate the gene specific primers
used for 5′-RLM-RACE.
is endogenously expressed in M-1 cells [9], and because
no rat CCD cell line is commercially available to our
knowledge. M-1 cells were transfected with pGL3-basic
alone, the full-length rat prostasin promoter in pGL3-
basic, or the rat prostasin promoter in reverse orien-
tation in pGL3-basic. Luciferase activity was measured
48 hours after transfection. The transcriptional activity of
the prostasin promoter was approximately 12-fold higher
than the control vector, and the construct that had the rat
prostasin promoter in the reverse orientation had no tran-
scriptional activity. These findings demonstrate that the
isolated gene fragment has definite transcriptional activ-
ity in M-1 cells (Fig. 3).
Effect of TGF-b1 on prostasin promoter activity
To determine if TGF-b1 can regulate the expression
of the prostasin gene, we transiently transfected the
prostasin promoter-luciferase construct into M-1 cells,
and investigated the effect of TGF-b1 on transcriptional
activity. Twenty-four hours after transfection, TGF-b1
was added to the culture media, and the cells were in-
cubated for an additional 24 hours. Figure 4A shows the
inhibitory effect of TGF-b1 on prostasin promoter activ-
ity that was significantly decreased by 50 ± 1% at a dose of
20 ng/mL. The inhibitory effect of TGF-b1 was observed
in a dose-dependent manner over the range of 0.1 ng/mL
to 20 ng/mL. We then studied the time course of the in-
hibitory effect of TGF-b1 on prostasin promoter activity
in M-1 cells. TGF-b1 significantly decreased promoter ac-
tivity after 6 hours of incubation, and the inhibitory effect
was observed up to 24 hours. These results demonstrate
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Fig. 3. Transcriptional activity of rat prostasin promoter in M-1 cells.
M-1 cells were transfected with pGL3-basic alone, the full-length rat
prostasin promoter in pGL3-basic, or the rat prostasin promoter in re-
verse orientation in pGL3-basic, and luciferase activity was measured
48 hours after transfection. The ratio of firefly luciferase activity to Re-
nilla luciferase activity was used to determine prostasin promoter activ-
ity and expressed as relative luciferase activity. Values are expressed as
mean ± SD (N = 12). ∗P < 0.001 as compared with pGL3-basic alone.
that TGF-b1 suppresses prostasin promoter activity in a
time- and concentration-dependent manner (Fig. 4B).
Identification of TGF-b1 responsive sequence
in prostasin promoter
In order to identify the promoter region that is re-
sponsible for TGF-b1–induced inhibition of rat prostasin
promoter activity, we created a series of truncated
rat prostasin promoter-luciferase constructs. These con-
structs were transfected into M-1 cells, and the effect of
20 ng/mL of TGF-b1 on promoter activity was deter-
mined after 24 hours of incubation. As shown in Figure 5,
the inhibitory effect of TGF-b1 was observed in P1
through P5; however, the effect was completely abolished
in the P6 construct. These findings show that a 50 bp re-
gion (−410 to −360) is responsible for TGF-b1–mediated
transcriptional inhibition of rat prostasin promoter
activity in M-1 cells. Analysis of transcription factor bind-
ing sites using the MatchTM program (http://www.gene-
regulation.com/) revealed a c-Rel motif-like sequence in
this region. Since TGF-b1 has been demonstrated to in-
hibit NF-jB/Rel activity by inducing IjBa in epithelial
cells and lymphocytes [23, 24], we next determined the
effect of TGF-b1 on the expression of IjBa in M-1 cells.
As shown in Figure 6, TGF-b1 significantly increased
the amount of IjBa at 6, 12, 24 hours compared with
the control, suggesting the possibility that TGF-b1 in-
hibits prostasin promoter activity through the induction
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Fig. 4. Effect of TGF-b1 on prostasin promoter activity in M-1 cells.
(A) Dose-dependent effect of TGF-b1 on prostasin promoter activ-
ity in M-1 cells. The prostasin promoter construct was cotransfected
with phRL-CMV into M-1 cells. Twenty-four hours after transfection,
the indicated doses of TGF-b1 were added to the culture medium and
incubated for an additional 24 hours. Values are expressed as fold in-
crease in relative luciferase activity over control. Data are expressed as
mean ± SD (N = 12). ∗P < 0.05. (B) Time course of inhibitory effect of
TGF-b1 on prostasin promoter activity in M-1 cells. Twenty-four hours
after transfection with the full-length rat prostasin promoter construct
and phRL-CMV, M-1 cells were treated with 20 ng/mL of TGF-b1 and
harvested at the indicated time points. Values are expressed as fold in-
crease in relative luciferase activity over control at 6 hours. Data are
expressed as mean ± SD (N = 8). ∗P < 0.05.
of IjBa and the subsequent inhibition of c-Rel activity in
M-1 cells.
Effect of TGF-b1 on endogenous prostasin mRNA and
protein expression in M-1 cells
Since M-1 cells express endogenous prostasin, we ex-
amined the effect of TGF-b1 on the endogenous expres-
sion of prostasin mRNA and protein. M-1 cells were
treated with 20 ng/mL of TGF-b1 for 24 hours, and total
RNA was extracted for Northern blot analysis. Northern
blot analysis indicated that TGF-b1 reduced mRNA ex-
pression of prostasin by approximately 50 ± 12% (Fig. 7).
Next, we studied the effect of TGF-b1 on the expres-
sion of endogenous prostasin protein in M-1 cells. Cells
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Fig. 5. Deletion mapping of promoter region for identification of TGF-
b1 responsive sequence. A series of truncated rat prostasin promoter-
luciferase constructs was created and transiently transfected into M-1
cells for the measurement of luciferase activity. The left panel shows
the series of promoter truncations, and the right panel shows the corre-
sponding promoter activity in the presence of 20 ng/mL of TGF-b1. Val-
ues are expressed as ratio of relative luciferase activity in the presence
of TGF-b1 over relative luciferase activity in the absence of TGF-b1.
Data are expressed as mean ± SD (N = 6). ∗P < 0.01.
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Fig. 6. Effect of TGF-b1 on IjBa expression in M-1 cells. M-1 cells,
which were serum-deprived for 24 hours, were treated with 20 ng/mL
of TGF-b1 and harvested after 6, 12, and 24 hours of incubation.
Thirty micrograms of cytosolic fraction was subjected to sodium do-
decyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The ex-
pression of IjBa protein was determined by immunoblotting using the
anti-IjBa antibody. The bands were quantitated with densitometry. The
blot shown is representative of 4 separate experiments. Values are ex-
pressed as fold increase over control. Data are expressed as mean ± SD
(N = 4). ∗P < 0.01 and #P < 0.05.
were treated with 20 ng/mL of TGF-b1 for 24 hours, and
the amount of prostasin protein in the culture medium,
membrane fraction, and cytosolic fraction were analyzed
by immunoblotting with our anti-prostasin antibody. As
shown in Figure 8, our new anti-prostasin antibody de-
tected prostasin protein both in culture media and in
membrane fraction under basal condition, but the abun-
dance of cytosolic prostasin was too low to study the effect
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Fig. 7. Effect of TGF-b1 on mRNA expression of prostasin in M-1
cells. M-1 cells, which were serum-deprived for 24 hours, were treated
with 20 ng/mL of TGF-b1 and harvested after 24 hours of incubation.
Total RNA was then extracted and used for the Northern blot analysis.
Each lane contains 20 lg of total RNA. The abundance of prostasin
mRNA was normalized for b-actin. This photograph is representative
of 4 separate experiments. Values are expressed as fold increase over
control. Data are expressed as mean ± SD (N = 4). ∗P < 0.02 as com-
pared with control.
of TGF-b1, even when 80 lg of cytosolic protein was sub-
jected to immunoblottings. TGF-b1 significantly reduced
the expression of prostasin protein in culture medium
and membrane fraction by 44 ± 12% and 43 ± 10%, re-
spectively. In our previous reports, we could not detect
prostasin protein in the membrane fraction of M-1 cells.
However, our new antibody made it possible to detect
the membrane-bound prostasin. Probably, the sensitivity
of the new antibody was much better than the previous
one.
Effect of TGF-b1 on amiloride-sensitive 22Na uptake in
M-1 cells
To determine if the TGF-b1–induced decrease in
prostasin abundance indeed has a role in the inhibi-
tion of ENaC activities in M-1 cells, we treated M-1
cells with 20 ng/mL of TGF-b1 or vehicle for 24 hours,
and measured amiloride-sensitive 22Na uptake. As shown
in Figure 9, treatment with TGF-b1 decreased the
amiloride-sensitive 22Na uptake by 35.9± 8.4%. These re-
sults suggest the possibility that the inhibition of prostasin
expression by TGF-b1 might play a part in the TGF-b1–
induced decrease in 22Na uptake in M-1 cells.
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Fig. 8. Effect of TGF-b1 on protein expression of prostasin in M-1 cells.
M-1 cells, which were serum-deprived for 24 hours, were treated with
20 ng/mL of TGF-b1 and harvested after 24 hours of incubation. Three
milliliters of culture medium, 20 lg of membrane fraction, and 80 lg
of cytosolic fraction were TCA-precipitated and subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). The
expression of prostasin protein was determined by immunoblotting us-
ing the anti-prostasin antibody. The bands were quantitated with den-
sitometry. The blot shown is representative of 5 separate experiments.
Values are expressed as fold increase over control. Data are expressed
as mean ± SD (N = 5). ∗P < 0.005.
DISCUSSION
In the present studies we isolated the rat prostasin
gene promoter and found that TGF-b1 decreased the
promoter activity, mRNA expression, and protein ex-
pression of prostasin in M-1 cells. TGF-b1 also inhibited
the amiloride-sensitive 22Na uptake in M-1 cells. In ad-
dition, we identified a 50 bp region (−410 to −360) in
the prostasin promoter that is responsible for TGF-b1–
induced inhibition of transcriptional activity.
TGF-bs are multifunctional growth factors that play
an important role in kidney growth and cell development
[11, 12]. Expression of TGF-b1 occurs in both glomeruli
and tubules [25], and renal production of TGF-b ac-
counts for the majority of urinary TGF-b . Previously,
Ying et al [17] reported that TGF-b1 is synthesized in
both glomeruli and tubules, and that a high salt diet
resulted in an increase in TGF-b1 production and ex-
cretion by the kidney. They suggested that augmented
expression of TGF-b1 in glomeruli due to a high salt diet
could play a role in the progression of glomerulosclerosis.
However, the precise mechanism and the pathophysio-
logic significance of the high salt diet–induced increase
in TGF-b1 synthesis in the kidney remain to be deter-
mined. We previously found that prostasin is a potent
activator of ENaC in the kidney [6], and that an increase
in urinary sodium excretion is associated with a decrease
in urinary prostasin excretion [19]. Also, in the current
studies we demonstrated that TGF-b1 significantly de-
creased prostasin expression and the amiloride-sensitive
22Na uptake in M-1 cells. Recently, Frank et al demon-
strated that TGF-b1 decreases sodium uptake by type II
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Fig. 9. Effect of TGF-b1 on amiloride-sensitive 22Na uptake in M-1
cells. M-1 cells, which were serum-deprived for 24 hours, were treated
with 20 ng/mL of TGF-b1 or vehicle for 24 hours. Amiloride-sensitive
22Na uptake was determined as the difference between 22Na uptake in
the presence or absence of 1 mmol/L amiloride. Values were expressed
as cpm/well. Data are expressed as mean ± SD (N = 6). ∗P < 0.05.
alveolar cells through a reduction in aENaC expression
[26]. This effect was mediated by an ERK1/2-dependent
inhibition of the aENaC promoter activity. In addition,
a recent report by Hughey et al demonstrated that the
proteolytic processing of a and c subunits of ENaC is re-
quired for the maturation of the channel [27]. Prostasin is
one of the candidate enzymes for processing this channel.
These findings collectively suggest the possibility that the
kidney increases TGF-b synthesis to compensate for the
salt overload by suppressing ENaC and prostasin expres-
sion. The increased TGF-b inhibits prostasin expression,
and could suppress the subsequent activation of ENaC by
prostasin. At the same time, the increased TGF-b directly
suppresses ENaC expression. Combination of inhibitory
effects of TGF-b1 on prostasin and ENaC expression
could enhance the sodium excretion through the kidney.
The findings reported by Houlihan et al may also support
this possibility [18]. They demonstrated a significant cor-
relation between urinary TGF-b and sodium excretion
in patients with type 2 diabetes and diabetic nephropa-
thy under basal conditions. Since they did not measure
dietary sodium intake in each patient at baseline, it is dif-
ficult to conclude that the urinary TGF-b that is produced
in the kidney indeed regulates urinary sodium excre-
tion independent of dietary salt loading. However, their
findings support the natriuretic role of TGF-b in the kid-
ney in humans. Therefore, it would be of interest to inves-
tigate urinary excretion of prostasin in those patients to
determine if an increase in urinary TGF-b1 is associated
with a decrease in urinary prostasin excretion. For that
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purpose, the development of a specific prostasin assay
system, such as ELISA or RIA, will be required.
The mechanisms by which TGF-b1 decreases prostasin
expression through inhibition of the prostasin promoter
activity are not fully defined in our study. However, we
identified a 50 bp region containing a c-Rel motif-like se-
quence in the rat prostasin promoter. TGF-b1 has been
demonstrated to inhibit NF-jB/Rel activity by induc-
ing IjBa in epithelial cells and lymphocytes [23, 24]. In
murine immature B cell lymphoma cells, TGF-b1 tran-
scriptionally induces IjBa protein, and subsequently in-
hibits NF-jB/Rel activities [23]. Also, TGF-b1 decreases
NF-jB/Rel activities by stabilizing IjBa protein in breast
cancer cell lines [24]. In our current studies, we observed
the increase in IjBa expression after 6 to 24 hours’ in-
cubation with TGF-b1 in M-1 cells, suggesting the pos-
sibility that the NF-jB/Rel and IjBa signaling system
might be involved in the TGF-b1–induced inhibition of
prostasin expression in M-1 cells.
CONCLUSION
We have shown that exposure of M-1 cells to TGF-b1
markedly down-regulates the expression of prostasin by
a transcriptional mechanism. The present study advances
the possibility that TGF-b1 may induce the inhibition of
sodium reabsorption in the collecting ducts of the kidney
through the down-regulation of prostasin expression, as
evidenced by a close correlation between urinary sodium
and TGF-b excretion in patients with type 2 diabetes.
Further studies are required to fully elucidate the detailed
regulatory mechanisms and the biological implications of
down-regulation of prostasin expression in the kidney.
ACKNOWLEDGMENTS
The authors thank Dr. R. Tyler Miller (Case Western Reserve Uni-
versity) for critical reading of the manuscript and for helpful discussions.
This work was supported by the Grants-in-Aid for Scientific Research
from the Ministry of Education, Culture, Sports, Science and Technol-
ogy in Japan (13770602 and 15790432 to K.K., 13877166 and 14370321 to
K.T.), and the Salt Science Research Foundation (0330 to K.K.). A part
of this work was presented at the 36th annual meeting of the American
Society of Nephrology in San Diego, 2003.
Reprint requests to Kenichiro Kitamura, M.D., Ph.D., Assistant Pro-
fessor, Department of Nephrology, Kumamoto University Graduate
School of Medical Sciences, 1–1-1 Honjo, Kumamoto, Kumamoto 860–
8556, Japan.
E-mail: ken@gpo.kumamoto-u.ac.jp
REFERENCES
1. CANESSA CM, SCHILD L, BUELL G, et al: Amiloride-sensitive ep-
ithelial Na+ channel is made of three homologous subunits. Nature
367:463–467, 1994
2. CANESSA CM, HORISBERGER JD, ROSSIER BC: Epithelial sodium
channel related to proteins involved in neurodegeneration. Nature
361:467–470, 1993
3. GARTY H, PALMER LG: Epithelial sodium channels: Function, struc-
ture, and regulation. Physiol Rev 77:359–396, 1997
4. YU JX, CHAO L, CHAO J: Prostasin is a novel human serine proteinase
from seminal fluid. Purification, tissue distribution, and localization
in prostate gland. J Biol Chem 269:18843–18848, 1994
5. YU JX, CHAO L, CHAO J: Molecular cloning, tissue-specific expres-
sion, and cellular localization of human prostasin mRNA. J Biol
Chem 270:13483–13489, 1995
6. ADACHI M, KITAMURA K, MIYOSHI T, et al: Activation of epithelial
sodium channels by prostasin in Xenopus oocytes. J Am Soc Nephrol
12:1114–1121, 2001
7. VALLET V, CHRAIBI A, GAEGGELER HP, et al: An epithelial serine
protease activates the amiloride-sensitive sodium channel. Nature
389:607–610, 1997
8. VUAGNIAUX G, VALLET V, JAEGER NF, et al: Activation of the
amiloride-sensitive epithelial sodium channel by the serine protease
mCAP1 expressed in a mouse cortical collecting duct cell line. J Am
Soc Nephrol 11:828–834, 2000
9. NARIKIYO T, KITAMURA K, ADACHI M, et al: Regulation of prostasin
by aldosterone in the kidney. J Clin Invest 109:401–408, 2002
10. WANG C, CHAO J, CHAO L: Adenovirus-mediated human prostasin
gene delivery is linked to increased aldosterone production and
hypertension in rats. Am J Physiol 284:R1031–R1036, 2003
11. LYONS RM, MOSES HL: Transforming growth factors and the regu-
lation of cell proliferation. Eur J Biochem 187:467–473, 1990
12. MASSAGUE J: Transforming growth factor-a. A model for
membrane-anchored growth factors. J Biol Chem 265:21393–21396,
1990
13. HUSTED RF, SIGMUND RD, STOKES JB: Mechanisms of inactivation
of the action of aldosterone on collecting duct by TGF-b . Am J
Physiol 278:F425–F433, 2000
14. HUSTED RF, MATSUSHITA K, STOKES JB: Induction of resistance to
mineralocorticoid hormone in cultured inner medullary collecting
duct cells by TGF-b1. Am J Physiol 267:F767–F775, 1994
15. HUSTED RF, STOKES JB: Separate regulation of Na+ and anion trans-
port by IMCD: Location, aldosterone, hypertonicity, TGF-b1, and
cAMP. Am J Physiol 271:F433–F439, 1996
16. STOKES JB: Physiologic resistance to the action of aldosterone. Kid-
ney Int 57:1319–1323, 2000
17. YING WZ, SANDERS PW: Dietary salt modulates renal production of
transforming growth factor-b in rats. Am J Physiol 274:F635–F641,
1998
18. HOULIHAN CA, AKDENIZ A, TSALAMANDRIS C, et al: Urinary trans-
forming growth factor-b excretion in patients with hypertension,
type 2 diabetes, and elevated albumin excretion rate: Effects of an-
giotensin receptor blockade and sodium restriction. Diabetes Care
25:1072–1077, 2002
19. IWASHITA K, KITAMURA K, NARIKIYO T, et al: Inhibition of prostasin
secretion by serine protease inhibitors in the kidney. J Am Soc
Nephrol 14:11–16, 2003
20. SHIRAISHI N, KITAMURA K, KOHDA Y, et al: Increased endothelin-1
expression in the kidney in hypercalcemic rats. Kidney Int 63:845–
852, 2003
21. VERGHESE GM, TONG ZY, BHAGWANDIN VJ, CAUGHEY GH: Mouse
prostasin gene structure, promoter analysis, and restricted expres-
sion in lung and kidney. Am J Respir Cell Mol Biol 30:519–529, 2003
22. YU JX, CHAO L, WARD DC, CHAO J: Structure and chromosomal lo-
calization of the human prostasin (PRSS8) gene. Genomics 32:334–
340, 1996
23. ARSURA M, WU M, SONENSHEIN GE: TGF beta 1 inhibits NF-jB/Rel
activity inducing apoptosis of B cells: Transcriptional activation of
IjBa. Immunity 5:31–40, 1996
24. SOVAK MA, ARSURA M, ZANIESKI G, et al: The inhibitory effects of
transforming growth factor b1 on breast cancer cell proliferation
are mediated through regulation of aberrant nuclear factor-jB/Rel
expression. Cell Growth Differ 10:537–544, 1999
25. ANDO T, OKUDA S, TAMAKI K, et al: Localization of transforming
growth factor-b and latent transforming growth factor-b binding
protein in rat kidney. Kidney Int 47:733–739, 1995
26. FRANK J, ROUX J, KAWAKATSU H, et al: Transforming growth factor-
b1 decreases expression of the epithelial sodium channel aENaC
and alveolar epithelial vectorial sodium and fluid transport via
an ERK1/2-dependent mechanism. J Biol Chem 278:43939–43950,
2003
27. HUGHEY RP, MUELLER GM, BRUNS JB, et al: Maturation of the ep-
ithelial Na+ channel involves proteolytic processing of the a- and
c-subunits. J Biol Chem 278:37073–37082, 2003
